Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis

• Main Authors: Elizabeth R. Packnett (Author), Nicole M. Zimmerman (Author), Patricia Novy (Author), Laura C. Morgan (Author), Nnenna Chime (Author), Parinaz Ghaswalla (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

In the United States (US), meningococcal serogroup B (MenB) vaccination has been recommended for 16-23-year-olds (preferably 16-18 years) based on shared clinical decision-making since 2015. MenB vaccine coverage (≥1 dose) by age 17 years has been reported, but initiation at older ages and by insura...